Fundraising Fox
/Companies
Sign in

Arsenal Medical

Watertown, US · Delaware corporation · 29 employees on LinkedIn · 1 known investors

Find your way into Arsenal Medical

Each arrow is one introduction. Sign up to fill in the first one.

268 people can intro you to Lee

Ask John Wright to introduce you to Lee Core

You →John · together at NMT Medical →Lee

129 people can intro you to Carol

Ask Jamie Chen to introduce you to Carol Pekar

You →Jamie · together at Anika Therapeutics →Carol

22 people can intro you to Alan

Ask Sam Okafor to introduce you to Alan Kilyk

You →Sam · together at Intact Vascular →Alan

Sign up to find every way you can get introduced to Arsenal Medical

  • Your email: who you already know at Arsenal Medical, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Arsenal Medical team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Arsenal Medical develops a platform of biomaterials for medical applications, including ResQFoam for hemorrhage control and NeoCast, advancing products through clinical trials and FDA regulatory pathways. The company focuses on biomaterial-based medical devices and combination products across clinical indications.

BiotechMedical DevicesNew Materials

Founders & leadership

USUpma Sharma
Upma SharmaPresident & CEOMedical, Biomaterials President, Arsenal Medicine at Material Impact
AKAlan Kilyk
Alan KilykChief Financial OfficerAlan Kilyk is Chief Financial Officer of Arsenal Medical, a biomaterial platform company developing medical devices for hemorrhage control and other clinical applications. He brings over 20 years of finance leadership experience, including work on mergers and acquisitions, regulatory compliance, and financial operations at public companies.
LCLee Core
Lee CoreChief Operating OfficerHe brings over 25 years of medical device development experience, including bringing multiple product lines through clinical and commercial stages, with expertise spanning product development, manufacturing, quality assurance, regulatory affairs, and business development across implantable devices, disposables, and combination products.
CPCarol Pekar
Carol PekarExecutive Vice President, Clinical and RegulatoryCarol Pekar holds an MBA from Babson and certificates in clinical research and regulatory affairs from Boston University School of Medicine and Northeastern University, respectively. She brings extensive experience in clinical trial management and FDA regulatory pathways across drugs, biologics, medical devices, and combination products, including 505(b)(2) NDAs, PMAs, HDEs, and 510(k)s, along with expertise in CE marking and international product approvals.
RW
Richard W MottNamed on SEC filing
TA
Thomas A FitzgeraldNamed on SEC filing
RL
Robert LangerCo-founder
GW
George WhitesidesCo-founder

Board

DD
Dennis DoughertyBoard directorManaging General Partner at Intersouth Partners
TM
Terrance McGuireBoard director
CR
Carmichael RobertsCo-founderGeneral Partner at North Bridge Venture Partners

Investors · 1

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 1 round · 2019

▶$6MraisedJun 2019 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard W MottDirector
  • Dennis DoughertyDirector
  • Thomas A FitzgeraldExecutive Officer
  • Robert LangerDirector
  • Terrance McGuireDirector
  • Carmichael RobertsDirector
  • George WhitesidesDirector
  • Upma SharmaExecutive Officer
Offering amount
$6M
Amount sold
$6M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

medcuraMedcura develops hemostatic products made from hydrophobically modified biopolymers to control minimal, mild, and moderate surgical bleeding through mechanical mucoadhesion. Its offerings target surgeons, patients, and payers in the surgical hemostasis market, including specialized applications such as spine surgery.

Companies working in the same space as Arsenal Medical.

Frequently asked questions

What does Arsenal Medical do?
Arsenal Medical develops a platform of biomaterials for medical applications, including ResQFoam for hemorrhage control and NeoCast, advancing products through clinical trials and FDA regulatory pathways. The company focuses on biomaterial-based medical devices and combination products across clinical indications.
Who are Arsenal Medical's investors?
Arsenal Medical's investors include North Bridge Venture Partners & Growth Equity.
How much funding has Arsenal Medical raised?
Arsenal Medical has disclosed $6M raised across 1 round.
Where is Arsenal Medical headquartered?
Arsenal Medical is headquartered in Watertown, US.